SMS Pharmaceuticals has announced a board meeting to allocate 40,00,000 equity shares, totaling Rs. 38.10 Crore, following the exercise of warrants by two allottees. The face value per share is Rs. 1 each, with the allotment price set at Rs. 95.25 per warrant. Post-allotment, the company’s paid-up share capital will increase to Rs. 88.65 Crore. This move reflects a strengthening of equity and indicates a proactive approach to capital management. Investors may view this development positively, as it enhances liquidity and supports future growth initiatives.